Intact SMAD-4 is a predictor of increased locoregional recurrence in upfront resected pancreas cancer receiving adjuvant therapyHunter C. Gits, Kenneth W. Merrell, Rondell P. Graham et al.|Journal of Gastrointestinal Oncology|2021Cited by 8
SMAD4 as a Predictive Biomarker For Locally Aggressive Phenotype In Resected Pancreas CancerHunter C. Gits, Kenneth W. Merrell, Amy Tang et al.|International Journal of Radiation Oncology*Biology*Physics|2020Cited by 2